BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28343356)

  • 1. Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
    Sashindranath M; Dwyer KM; Dezfouli S; Selan C; Crikis S; Lu B; Yuan Y; Hickey MJ; Peter K; Robson SC; Cowan PJ; Nandurkar HH
    Purinergic Signal; 2017 Jun; 13(2):259-265. PubMed ID: 28343356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
    Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
    Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
    J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
    Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM
    Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of extracellular ATP metabolism in regulation of platelet reactivity.
    Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
    J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.
    Buergler JM; Maliszewski CR; Broekman MJ; Kaluza GL; Schulz DG; Marcus AJ; Raizner AE; Kleiman NS; Ali NM
    J Thromb Thrombolysis; 2005 Apr; 19(2):115-22. PubMed ID: 16052302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
    Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
    Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human solCD39 inhibits injury-induced development of neointimal hyperplasia.
    Drosopoulos JH; Kraemer R; Shen H; Upmacis RK; Marcus AJ; Musi E
    Thromb Haemost; 2010 Feb; 103(2):426-34. PubMed ID: 20024507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Alyonycheva TN; Safier LB; Hajjar KA; Posnett DN; Schoenborn MA; Schooley KA; Gayle RB; Maliszewski CR
    J Clin Invest; 1997 Mar; 99(6):1351-60. PubMed ID: 9077545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of purinergic signaling on renal ischemia-reperfusion injury.
    Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.
    Hart ML; Gorzolla IC; Schittenhelm J; Robson SC; Eltzschig HK
    J Immunol; 2010 Apr; 184(7):4017-24. PubMed ID: 20207994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
    Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
    J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment.
    Drosopoulos JH; Broekman MJ; Islam N; Maliszewski CR; Gayle RB; Marcus AJ
    Biochemistry; 2000 Jun; 39(23):6936-43. PubMed ID: 10841775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain.
    Pinsky DJ; Broekman MJ; Peschon JJ; Stocking KL; Fujita T; Ramasamy R; Connolly ES; Huang J; Kiss S; Zhang Y; Choudhri TF; McTaggart RA; Liao H; Drosopoulos JH; Price VL; Marcus AJ; Maliszewski CR
    J Clin Invest; 2002 Apr; 109(8):1031-40. PubMed ID: 11956240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
    Atkinson B; Dwyer K; Enjyoji K; Robson SC
    Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.
    Hyman MC; Petrovic-Djergovic D; Visovatti SH; Liao H; Yanamadala S; Bouïs D; Su EJ; Lawrence DA; Broekman MJ; Marcus AJ; Pinsky DJ
    J Clin Invest; 2009 May; 119(5):1136-49. PubMed ID: 19381014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.